未登录

L

Lukas Weigl

Medical University of Vienna

H指数:19

被引数:835

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutation

携带激活SOS1突变的BH1406非小细胞肺癌 (NSCLC) 细胞系的表征

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2024-11-010

OAAI

Nuclear Magnetic Resonance Treatment Induces ßNGF Release from Schwann Cells and Enhances the Neurite Growth of Dorsal Root Ganglion Neurons In Vitro

IF5.2

2024-09-130

OAAI

Nuclear Magnetic Resonance Treatment Accelerates the Regeneration of Dorsal Root Ganglion Neurons in vitro

FRONTIERS IN CELLULAR NEUROSCIENCE

IF4

2022-03-285

OAAI

Mechanical exposure and diacerein treatment modulates integrin-FAK-MAPKs mechanotransduction in human osteoarthritis chondrocytes

CELLULAR SIGNALLING

IF3.7

2019-04-0139

OAAI

CONDITIONED MEDIUM FROM CHONDROCYTES AND SYNOVIOCYTES DERIVED FROM OA PATIENTS MODULATES EXCITABILITY OF NEUROBLASTOMA CELLS (NERVE CELLS)

OSTEOARTHRITIS AND CARTILAGE

IF9

2018-04-010

OAAI

CYCLIC TENSILE STRAIN AND PHARMACOLOGICAL TREATMENT AFFECTS HUMAN CHONDROCYTES UNDER INFLAMMATORY AND NON-INFLAMMATORY CONDITIONS

OSTEOARTHRITIS AND CARTILAGE

IF9

2018-04-010

OAAI

The disease modifying osteoarthritis drug diacerein is able to antagonize pro inflammatory state of chondrocytes under mild mechanical stimuli

OSTEOARTHRITIS AND CARTILAGE

IF9

2014-07-0126

OAAI

THE DISEASE MODIFYING OSTEOARTHRITIS DRUG DIACEREIN IS ABLE TO ANTAGONIZE PRO INFLAMMATORY STATE OF CHONDROCYTES UNDER MILD MECHANICAL STIMULI

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2014-06-010

PREAI

3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility

PHARMACOLOGICAL RESEARCH

IF10.5

2012-07-010

PRE

Lost in translation: regulation of skeletal muscle protein synthesis

CURRENT OPINION IN PHARMACOLOGY

IF4.2

2012-06-0149

PREAI

Influence of nmr therapy on metabolism of osteosarcoma- and chondrosarcoma cell lines

IF3.6

2009-06-015

PREAI

Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytes

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2009-01-3015

OAAI

Novel ryanodine receptor mutation that may cause malignant hyperthermia

IF9.1

2008-09-0112

OA

Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells

BIOCHEMICAL PHARMACOLOGY

IF5.6

2006-05-0147

PREAI

Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2005-09-0188

PREAI

Store operated Ca2+ influx by selective depletion of ryanodine sensitive Ca2+ pools in primary human skeletal muscle cells

通过选择性消耗原代人骨骼肌细胞中ryanodine敏感的Ca2库来存储操作的Ca2流入

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2003-04-0121

PREAI